NovaBay Pharmaceuticals: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
[[Category:Companies listed on the New York Stock Exchange]] | [[Category:Companies listed on the New York Stock Exchange]] | ||
{{pharma-company-stub}} | {{pharma-company-stub}} | ||
== NovaBay Pharmaceuticals == | |||
<gallery> | |||
File:2000_Powell_Street,_Emeryville.jpg | |||
</gallery> | |||
Revision as of 22:12, 16 February 2025
NovaBay Pharmaceuticals is an American biopharmaceutical company that specializes in the development, manufacturing, and commercialization of non-antibiotic anti-infective products. The company was founded in 2000 and is headquartered in Emeryville, California.
History
NovaBay Pharmaceuticals was established in the year 2000 with the aim of developing innovative therapies for the treatment of a wide range of infections without causing antibiotic resistance. The company's initial focus was on the development of products that mimic the action of the human immune system.
Products
NovaBay Pharmaceuticals has developed several products, including Avenova, a prescription product for the management of blepharitis and the associated bacterial skin infection. Avenova is the only commercial product that contains NovaBay's proprietary, pure hypochlorous acid.
Research and Development
NovaBay Pharmaceuticals' research and development efforts are focused on the company's proprietary, pure hypochlorous acid. The company's research team is working on developing new formulations and applications for this compound.
Financials
As a publicly traded company, NovaBay Pharmaceuticals' financial performance is subject to regular reporting. The company's stock is traded on the New York Stock Exchange under the ticker symbol "NBY".
See Also
References
<references />
This article is a pharmacology-related stub. You can help WikiMD by expanding it!
